![](http://www.sibionicscgm.com/cdn/shop/files/about_01.jpg?v=1699128490&width=1600)
![](http://www.sibionicscgm.com/cdn/shop/files/20240427104618.jpg?v=1714186085&width=1600)
SIBIONICS
Innovating for You: Revolutionizing Diabetes Care with Every Step.
Since our founding in 2015, SIBIONICS has been at the forefront of transforming diabetes management. Born from a commitment to innovation and a profound understanding of the everyday challenges faced by those with diabetes, we've consistently aimed to redefine the landscape of Continuous Glucose Monitoring (CGM) systems. By merging cutting-edge technology with designs centered around the user, we deliver solutions that not only meet needs but exceed expectations.
Today, with over 1,000,000 users across the globe, SIBIONICS stands as a beacon of reliability and innovation in diabetes care. Our global presence is a testament to the effectiveness of our CGM solutions and our dedication to making a significant, positive impact worldwide.
Looking ahead, SIBIONICS is committed to continuing our legacy of innovation. We're not just keeping pace; we're setting the pace—constantly pushing the boundaries of what's possible in CGM technology and striving for excellence with each new product we introduce.
Иновирайте основните технологии в услуга на общественото здраве
Ние се фокусираме върху нуждите от управление на здравеопазването на най-голямата част от населението и също така се грижим за диагностицирането на заболявания и терапевтичните режими на популации с редки заболявания. Интегрирахме отличен екип от учени, за да трансформираме непрекъснато най-съвременните научни постижения в медицински продукти и да служим на общественото здраве.
![](http://www.sibionicscgm.com/cdn/shop/files/09._About_us-01.jpg?v=1699129070&width=1080)
![](http://www.sibionicscgm.com/cdn/shop/files/09._About_us-02.jpg?v=1699129276&width=1080)
Технологичните прозрения за непознатото събуждат потенциал за живот
Въз основа на нуждите на пациентите ние въвеждаме биохимия, дизайн на чипове, изкуствен интелект, автоматизация и други технологии, за да вникнем в непознатите области на здравни данни и да помогнем на хората да направят промени към по-добро качество на живот
Сертификати
Ние сме посветени на подпомагането на клиентите да подобрят качеството на продукта и да се справят с предизвикателствата.
![](http://www.sibionicscgm.com/cdn/shop/files/01_2a9ffbd6-563b-419e-b178-65c0f45c7145.jpg?v=1699339519&width=1600)
Важни етапи и продуктова гама
![](http://www.sibionicscgm.com/cdn/shop/files/CGM_CE.jpg?v=1699118778&width=1600)
2023
The GS1 CGM system received the CE mark for entering the European market.
![](http://www.sibionicscgm.com/cdn/shop/files/09._About_us-07.jpg?v=1699133981&width=1600)
2021
The continuous glucose monitoring system (CGM) was submitted to National Medical Products Administration for registration and was approved. The practicing license of Yinchuan Sibionics Internet Hospital was approved.
![](http://www.sibionicscgm.com/cdn/shop/files/09._About_us-06.jpg?v=1699133932&width=1600)
2020
AI-DR was approved as the first Class III medical device for AI-assisted fundus disease diagnosis software in China. Sibionics was certified as National High-tech Enterprise.
![](http://www.sibionicscgm.com/cdn/shop/files/09._About_us-05.jpg?v=1699133891&width=1600)
2019
Fundus camera obtained the registration certificate for Class II medical device. R&D of capsule endoscopy project was started.
![](http://www.sibionicscgm.com/cdn/shop/files/09._About_us-04.jpg?v=1699133543&width=1600)
2016
R&D of continuous glucose monitoring system (CGM) was started. R&D of diabetic retinopathy AI-assisted diagnosis software (AI-DR) was started.
![](http://www.sibionicscgm.com/cdn/shop/files/09._About_us-03.jpg?v=1699133355&width=1600)
2015
Sibionics was established, and American R&D Center was established. R&D of artificial retina project was started.